Nudging Healthcare Organizations to Adopt New Care Delivery Practices

Sponsor
Dartmouth-Hitchcock Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04176146
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
2,387
1
2
6
399.2

Study Details

Study Description

Brief Summary

This two-arm, parallel group randomized controlled trial will assess the impact of written social norms messaging (i.e., behavioral 'nudges') on healthcare organization administrators' decision to access online resources that support the adoption of evidence-based healthcare delivery practices. The healthcare delivery practices include the use of population screening tools, clinical practice guidelines, and shared decision making training.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Peer comparison and social norms messaging
N/A

Detailed Description

The purpose of this study is to assess if behavioral 'nudges' impact the likelihood of healthcare organization administrators accessing technical assistance resources to support uptake of care delivery practices that: (1) have the potential to improve patient outcomes; and (2) have already been adopted by most healthcare organizations. A 'nudge' is a change in the way information is presented that attempts to steer people in a certain direction but does not restrict their choices.

The investigator will conduct a randomized controlled trial of written messages to healthcare administrators at three types of healthcare organizations - physician practices, hospitals and healthcare systems - from among 3,402 administrators who completed Dartmouth's National Survey of Healthcare Organizations and Systems (NSHOS) in 2017-2018.

In Fall 2019 the investigator will mail a customized report to all NSHOS respondents that compares their organizations' survey responses to their peer organizations. The investigator will randomize the 2,387 respondents whose organizations have not implemented one or more of up to seven chosen care delivery practices to cover letters with or without social norms messaging. The written messaging in the 'control condition' cover letter lists the practices for which the NSHOS team has prepared technical assistance materials in support of practice adoption, and contains a link to these online resources. The 'intervention condition' additionally highlights the organization's performance compared to its peers in adopting the practices using visual data display and explicit social norms messaging.

Study Design

Study Type:
Interventional
Actual Enrollment :
2387 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
Accelerating the Use of Evidence-based Innovation in Health Care Systems
Actual Study Start Date :
Dec 9, 2019
Actual Primary Completion Date :
Feb 9, 2020
Actual Study Completion Date :
Jun 8, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nudge Letter

Participants receive a letter that highlights their performance vs. peer organizations on up to seven care delivery practices featured in the National Survey of Healthcare Organizations and Systems (NSHOS). The letter includes a link to access technical assistance resources and is sent alongside the participant's NSHOS respondent report.

Behavioral: Peer comparison and social norms messaging
This group will receive a letter noting that their organization has not implemented at least one common care delivery practice that a majority their peers have already implemented. The letter will also note the percentage of peer organizations that have implemented the practice. This is done using peer comparison data and social norms messaging.

No Intervention: Control Letter

Participants receive a letter with a link to technical assistance resources; the letter is sent alongside the participant's NSHOS survey respondent report.

Outcome Measures

Primary Outcome Measures

  1. Percentage of participants who access the technical assistance resource webpage [Up to 2 months after letter is sent]

    The percentage of participants who access the technical assistance webpage will be determined by email and webpage analytics. The primary analysis will be intention to treat (i.e., among all participants sent a letter); a secondary analysis will be a 'per protocol' analysis (i.e., among all participants whose letter was not sent back as undeliverable). Exploratory sub-group analyses will be conducted by each strata characteristic (e.g., whether organization category influences the likelihood of accessing the webpage).

Secondary Outcome Measures

  1. Number of unique resource views on technical assistance resource webpage [Up to 2 months after letter is sent]

    The number of unique resources viewed from the webpage, as determined by website analytics.

  2. Percentage of participants who request connection to peer organizations via the technical assistance resource webpage [Up to 2 months after letter is sent]

    The number of unique organizations that request to be matched with other healthcare organizations that have successfully implemented one of the care delivery practices, in order to learn from their experiences (there will be a clickable link on the webpage for organizations to request this connection). This will be determined by website analytics.

  3. Perceived effect of letter on administrators' intentions [Up to 4 months after letter is sent]

    Effect of letter on administrators' intentions and actions, measured by qualitative interviews in a sub-sample of participants.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participant responded to NSHOS survey and reported that their organization had not implemented at least one of up to seven pre-determined care delivery practices, out of the following eight practices featured in the NSHOS: Screening for opioid use specifically; Screening for substance use disorders; Screening for depression; Screening for interpersonal violence; Method for identifying high-cost patients; Use of evidence-based guidelines for congestive heart failure; Use of evidence-based guidelines for sepsis (included in letters to healthcare system administrators, but not hospitals or physician practices); Training for shared decision making (included in letters to hospitals and physician practices but not healthcare systems)
Exclusion Criteria:
  • Did not respond to NSHOS survey

  • Participant responded to NSHOS survey and reported that their organization had already implemented each of seven pre-determined care delivery practices, out of the following eight practices featured in the NSHOS: Screening for opioid use specifically; Screening for substance use disorders; Screening for depression; Screening for interpersonal violence; Method for identifying high-cost patients; Use of evidence-based guidelines for congestive heart failure; Use of evidence-based guidelines for sepsis (included in letters to healthcare system administrators, but not hospitals or physician practices); Training for shared decision making (included in letters to hospitals and physician practices but not healthcare systems)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dartmouth Hitchcock Medical Center Lebanon New Hampshire United States 03766

Sponsors and Collaborators

  • Dartmouth-Hitchcock Medical Center
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Amber E Barnato, MD, MPH, MS, Dartmouth College

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amber Barnato, Professor of Health Policy and Clinical Practice and of Medicine, Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT04176146
Other Study ID Numbers:
  • Dartmouth IRB protocol #28763
  • 1U19HS024075
First Posted:
Nov 25, 2019
Last Update Posted:
Jun 26, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 26, 2020